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ADENOID CYSTIC CARCINOMA OF DISTAL TRACHEA:  
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SUMMARY – Primary malignant tumors of the trachea are very rare with the incidence of less 
than two per million people per year, and only ten percent of them are adenoid cystic carcinomas. 
Eighty percent of all tracheal tumors are malignant. Diagnosis is usually late because the symptoms 
mimic other conditions such as asthma. Clinical picture may sometimes be dramatic when airway is 
almost closed and emergency recanalization is necessary. Diagnosis is made by chest computed to-
mography scan or magnetic resonance imaging. Definitive treatment is surgical resection alone or 
followed by radiation therapy or radiation therapy alone. Radical resection is only accomplished in 
about half of all cases because of the submucosal tumor growth and limited length of tracheal resec-
tion. The role of adjuvant radiation therapy in negative resection margin cases is not clear but all pa-
tients with positive resection margin benefit from radiation therapy. We present a case of a 43-year-old 
patient with primary adenoid cystic carcinoma of distal trachea treated by emergency bronchoscopic 
recanalization and resection of the tracheal tumor with end-to-end anastomosis.
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Introduction
Primary malignant tumors of the trachea are very 
rare with the incidence of less than two per million 
people per year and they account for less than one per-
cent of all malignant tumors1,2. Eighty percent of all 
tracheal tumors are malignant2. Most common are 
squamous cell carcinoma (SCC) and adenoid cystic 
carcinoma (ACC)1,2. While SCC is usually located in 
the distal part, ACC is usually located in the proximal 
part of the trachea1. ACC grows slowly and clinical 
course is long. It metastasizes to distant sites and can 
recur after a long interval. Treatment of choice is sur-
gical resection. If the tumor is too large for resection or 
unresectable due to invasion of adjacent organs, radio-
therapy is used1-7. We present a case of a 43-year-old 
male patient, member of the cruise ship staff. He was 
hospitalized for severe stridor and dyspnea and diag-
nosed with distal tracheal tumor that was not SCC but 
ACC. This is a rare presentation of this type of tumor 
and any report of ACC is valuable for data accumula-
tion. This case is specific for unusual localization in 
distal trachea.
Case Report
A 43-year-old patient with dyspnea and severe 
stridor was hospitalized in a general hospital. Com-
puted tomography (CT) scan of the chest revealed dis-
tal tracheal tumor almost obstructing complete lumen 
of distal trachea (Figs. 1 and 2). The patient was intu-
bated and transferred to our hospital. After broncho-
scopic assessment, an intervention was performed. 
About half of the tumor volume was removed by bron-
choscopic excision. Tracheal lumen was re-established 
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He was discharged on postoperative day 8. Adjuvant 
radiation therapy was recommended.
Discussion
Primary ACC, previously also called cylindroma, is 
a rare tumor1,2. Only two cases of tracheal tumors per 
million people per year are recorded, with ACC ac-
counting for about ten percent of these8. Both sexes are 
affected equally in the fifth decade of life. It is not a 
smoking related condition9. Usual symptoms are 
cough, wheezing and dyspnea, and patients are often 
treated for asthma before reaching an accurate diagno-
sis2,3. This tumor does not have a capsule and spreads 
directly by submucosal or perineural invasion. More 
than half of these patients have metastatic disease by 
hematogenous spread2. Lung is the most common site 
of metastases. Other affected organs are brain, liver, 
kidney, skin and bone7,10. Typical presentation is intra-
luminal mass on chest CT scan, which infiltrates tra-
cheal wall and obstructs airway.
Treatment includes surgery, radiation therapy, or a 
combination of both. If possible, resection with end-
to-end anastomosis should be performed. It is the best 
option for localized lesion. The nature of spread is the 
most important reason for incomplete resection11. The 
rates of reported complete resections are around fifty 
percent1,8. In this case, adjuvant radiation therapy is 
mandatory1,5,9. There are controversies about adjuvant 
radiation therapy in clear margin cases and local versus 
systemic radiation therapy1,4,9. In our case, we recom-
Fig. 1. Chest CT scan showing tumor in distal trachea 
with barely patent lumen (arrow) – axial view.
Fig. 2. Chest CT scan showing tumor in distal trachea 
with barely patent lumen (arrow) – coronal view.
Fig. 3. Bronchoscopy showing precarinal anastomosis 
with both main bronchi.
by photocoagulation and additional dilatation. Pre-
cisely determined localization after bronchoscopic in-
tervention revealed a tumor one centimeter proximally 
to the carina infiltrating anterior wall of the trachea by 
about three centimeters in length. Histopathology 
confirmed primary ACC. Three days after tracheal re-
canalization, right thoracotomy, resection of the af-
fected part of the trachea and mediastinal lymphade-
nectomy was performed. The supracarinal segment of 
the trachea was resected and end-to-end anastomosis 
created. Histopathology revealed submucosal spread of 
the tumor with a positive margin. Anastomosis healed 
well and follow up bronchoscopy status was satisfac-
tory (Fig. 3). The patient had no respiratory problems. 
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mended adjuvant radiation therapy because there was 
positive margin on histopathology.
Conclusion
Adenoid cystic carcinoma is an extremely rare con-
dition with less than one case per year in our country. 
The symptoms are somewhat confusing and can lead 
to misdiagnosing and wrong treatment. Once the ac-
curate diagnosis is made, treatment options are narrow 
and include surgery alone, radiation therapy, or a com-
bination of both. Survival is almost the same for pa-
tients treated by surgery only and those treated by ad-
juvant radiation therapy but data on this are not satis-
factory. The reason for that is the small number of 
cases and inadequate follow up. However, it is clear 
that all patients with positive resection margin need 
adjuvant radiation therapy. In these cases, oncologic 
approach is restricted by anatomic limitations and 
poses a therapeutic challenge. Individual approach to 
every patient is needed.
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Sažetak
ADENOIDNI CISTIČNI KARCINOM DISTALNE TRAHEJE: PRIKAZ SLUČAJA
Ž. Djaković, Z. Janevski, V. Cesarec, Z. Slobodnjak i D. Stančić-Rokotov
Primarni maligni tumori traheje su iznimno rijetki s incidencijom manjom od dva slučaja na milijun stanovnika u jednoj 
godini, a adenoidni cistični karcinom čini samo deset posto. Osamdeset posto svih tumora traheje je maligno. Dijagnoza se 
obično postavlja kasno, jer su početni simptomi slični astmi. Ponekad je klinička slika dramatična kada dođe do opstrukcije 
dišnog puta i potrebe za hitnom rekanalizacijom. Dijagnoza se potvrđuje kompjutorskom tomografijom prsišta ili magnet-
nom rezonancom. Definitivno liječenje je resekcija tumora sama ili uz adjuvantnu radioterapiju, ili radioterapija sama. Radi-
kalna resekcija se postiže samo u oko polovice svih slučajeva zbog submukoznog rasta tumora i ograničene duljine resekcije 
traheje. Uloga adjuvantne radioterapije u slučajevima s negativnim resekcijskim rubom je nejasna, dok svi bolesnici s pozitiv-
nim resekcijskim rubom imaju koristi od adjuvantne radioterapije. Prikazujemo slučaj 43-godišnjeg bolesnika s adenoidnim 
cističnim karcinomom distalnog dijela traheje koji je liječen bronhoskopskom rekanalizacijom i resekcijom traheje s termino-
terminalnom anastomozom.
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